Assessment of the status of DNA mismatch repair proteins by immunohistochemistry. Proposal for evaluation with two antibodies
Polish Journal of Pathology · 13.03.2025 · 76 (1) · 54-58
DOI: 10.5114/pjp.2025.148390 ↗Kurz gefasst
Fallbericht in der Zeitschrift Polish Journal of Pathology, online erschienen am 13.03.2025. Verfasst von Leonardo Saul Lino-Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional De Cancerologia De Mèxico, Mexico City, Mexico. Hauptthemen laut MEDLINE: DNA Mismatch Repair, Mismatch Repair Endonuclease PMS2, Immunohistochemistry, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Determining the status of DNA mismatch repair (MMR) proteins is crucial for patients because they may respond differently to specific treatments and have a better prognosis. We proposed a panel with only 2 antibodies to determine the status of the MMR proteins, improving costs, workload, and delivery of results. Patients with adenocarcinoma and MMR determination were reclassified using only the evaluation of PMS2 and MSH6. The diagnostic performance of the 2-antibody test (proposed panel) and 4-antibody (traditional panel) test was compared against the polymerase chain reaction study (reference standard). A total of 202 cases were identified. The predominant histological type was adenocarcinoma not otherwise specified, the predominant histological grade was 2, and 60.9% of the cases were found in clinical stage II. When comparing the diagnostic performance of the traditional panel of 4 antibodies against a panel of 2 antibodies, no statistically significant differences were found (sensitivity 95.35% vs. 90.7%; specificity 98.74% vs. 98.11%; positive predictive value 95.35% vs. 92.86%; negative predictive value 98.74% vs. 97.50%; area under the curve 0.970 vs. 0.944; p = 0.419).Analysis of MMR status determination with only 2 antibodies demonstrates that it is as effective as using 4 antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Nacional De Cancerologia De Mèxico, Mexico City, Mexico.
- AFINES program, Medicine Faculty, National Autonomous University of Mexico (UNAM), Coyoacan, Mexico City, Mexico.
- Hospital Angeles Tijuana, Tijuana, Baja California Norte, Mexico.
Zitieren
APA
Saul Lino-Silva, L., Galán-Ramírez, Á., Martínez-Villavicencio, S. B., Rivera-Moncada, L., Zepeda-Najar, C., & Ortega-Martínez, H. I. (2025). Assessment of the status of DNA mismatch repair proteins by immunohistochemistry. Proposal for evaluation with two antibodies. Polish Journal of Pathology, 76(1), 54-58. https://doi.org/10.5114/pjp.2025.148390
Vancouver
Saul Lino-Silva L, Galán-Ramírez Á, Martínez-Villavicencio SB, Rivera-Moncada L, Zepeda-Najar C, Ortega-Martínez HI. Assessment of the status of DNA mismatch repair proteins by immunohistochemistry. Proposal for evaluation with two antibodies. Polish Journal of Pathology. 2025;76(1):54-58. doi:10.5114/pjp.2025.148390
BibTeX
@article{SaulLinoSilva2025,
author = {Saul Lino-Silva, Leonardo and Galán-Ramírez, Ángeles and Martínez-Villavicencio, Sabrina B and Rivera-Moncada, Luisa and Zepeda-Najar, César and Ortega-Martínez, Hanna I},
title = {Assessment of the status of DNA mismatch repair proteins by immunohistochemistry. Proposal for evaluation with two antibodies},
journal = {Polish Journal of Pathology},
year = {2025},
volume = {76},
number = {1},
pages = {54--58},
doi = {10.5114/pjp.2025.148390}
}
EUVIMED